Thursday 1/28 Insider Buying Report: OVLY, TCON

Thursday 1/28 Insider Buying Report: OVLY, TCON

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

At Oak Valley Bancorp, a filing with the SEC revealed that on Wednesday, Director H.

Randolph Holder Jr. bought 10,000 shares of OVLY, for a cost of $15.47 each, for a total investment of $154,700.

So far Holder Jr. is in the green, up about 1.4% on their purchase based on today's trading high of $15.68.

Oak Valley Bancorp is trading up about 1.6% on the day Thursday.

Before this latest buy, Holder Jr. bought OVLY on 9 other occasions during the past year, for a total cost of $245,211 at an average of $14.86 per share.

And also on Wednesday, CEO Charles Theuer purchased $98,771 worth of TRACON Pharmaceuticals, purchasing 11,000 shares at a cost of $8.98 a piece.

Before this latest buy, Theuer purchased TCON on 10 other occasions during the past year, for a total investment of $268,817 at an average of $1.95 per share.

TRACON Pharmaceuticals is trading up about 9.1% on the day Thursday.

Theuer was up about 13.8% on the buy at the high point of today's trading session, with TCON trading as high as $10.22 in trading on Thursday.